These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11885393)

  • 21. FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults.
    AIDS Alert; 2005 Jul; 20(7):83-4. PubMed ID: 16114113
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
    Sherman KE; Fleischer R; Laessig K; Murray J; Tauber W; Birnkrant D;
    Hepatology; 2007 Dec; 46(6):2014-20. PubMed ID: 18027878
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1998; ():32. PubMed ID: 11367504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA notifications. New treatment approved for chronic hepatitis B.
    AIDS Alert; 2002 Nov; 17(11):146-7. PubMed ID: 12412570
    [No Abstract]   [Full Text] [Related]  

  • 25. New drug approvals in 2000.
    Wynn RL
    Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA allows second experimental drug to be tested in Ebola patients.
    McCarthy M
    BMJ; 2014 Aug; 349():g5103. PubMed ID: 25113141
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010.
    Pariser AR; Slack DJ; Bauer LJ; Warner CA; Tracy LA
    Drug Discov Today; 2012 Aug; 17(15-16):898-904. PubMed ID: 22564486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral ulcers remedy gets FDA clearance.
    J Am Dent Assoc; 1994 Oct; 125(10):1308, 1310. PubMed ID: 7844295
    [No Abstract]   [Full Text] [Related]  

  • 30. New drug approvals in 1996.
    Wynn RL
    Gen Dent; 1997; 45(3):224-7. PubMed ID: 9515422
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
    AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
    Hoffman KB; Demakas A; Erdman CB; Dimbil M; Doraiswamy PM
    BMJ; 2013 Jul; 347():f4656. PubMed ID: 23881998
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 36. 1992 FDA drug approvals.
    Wynn RL
    Gen Dent; 1993; 41(4):286-7. PubMed ID: 8262339
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
    Tanne JH
    BMJ; 2007 Jan; 334(7586):177. PubMed ID: 17255596
    [No Abstract]   [Full Text] [Related]  

  • 38. Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.
    Riner A; Chan-Tack KM; Murray JS
    Postgrad Med; 2009 May; 121(3):139-46. PubMed ID: 19491552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.